TCS
WVE icon

Texas Children's’s Wave Life Sciences WVE Stock Holding History

Texas Children's’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-30,546
Closed -$1.19M – 15
2019
Q1 		$1.19M Buy
30,546
+13,267
+77% +$538K 1.44% 7
2018
Q4 		$726K Buy
+17,279
New +$768K 1.01% 14

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Texas Children's's WVE Position: Q2 2019 in Review

Texas Children's sold out of Wave Life Sciences (WVE) in Q2 2019, closing a stake of 30,546 shares — an estimated $1.19M sold.

Texas Children's first reported a position in WVE in Q4 2018 and held it in 2 quarters. The position peaked at $1.19M in Q1 2019. 100 funds tracked by Wall St. Rank hold WVE as of Q2 2019.

  • Texas Children's reported no remaining Wave Life Sciences position as of Q2 2019 after selling out during the quarter.
  • Texas Children's sold 30,546 Wave Life Sciences shares in Q2 2019, an estimated $1.19M.
  • Texas Children's first reported a position in Wave Life Sciences in Q4 2018 and held it in 2 quarters.
  • Texas Children's's Wave Life Sciences position peaked at $1.19M in Q1 2019.
  • 100 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2019.

Based on Texas Children's's 13F filing for Q2 2019, filed 13 Aug 2019.